Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy
Abstract
Osteoporosis is a major problem in patients with Duchenne muscular dystrophy (DMD), due to glucocorticoid therapy and muscle weakness. Evidence on which to base optimal prevention and treatment strategies, including bisphosphonate use, in DMD are limited. Our objective was to describe bone health outcomes of oral alendronate treatment in patients with DMD and glucocorticoid-induced osteoporosis. We retrospectively studied 54 patients treated...
Paper Details
Title
Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy
Published Date
Jul 1, 2020
Journal
Volume
30
Issue
7
Pages
599 - 610
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History